EFDID: 584598EFD: View Filing

Issuer: Ensho Therapeutics, Inc. (0002032849) - D

Accession: 0002032849-26-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002032849
  • Entity Name:
    Ensho Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2024)
  • Address:
    50 Tice Boulevard
    Suite 340 - #1005
    Woodcliff Lake, NJ 07677
  • Persons:
    Related Persons 5
    Danielle Fry
    Executive Officer
    Arash Rassoulpour
    Director
    Carlos Solorzano
    Director
    Eric Pham
    Director
    Gerhard Hagn
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/09/2026
  • First Sale Date:
    01/20/2026
  • Offering Amount:
    $20,000,000
  • Amount Sold:
    $0
  • Amount Remaining:
    $20,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ensho Therapeutics, Inc./s/ Danielle FryDanielle FryChief Legal Officer & Chief Operating Officer2026-02-09